Worldwide, transgender women are at disproportionately higher risk of HIV infection, with the primary mode of infection being condomless anal intercourse. Although very few HIV prevention interventions have been developed and tested specifically for transgender women, growing evidence suggests that behavioral HIV risk reduction interventions for other marginalized groups are efficacious. We outline the current state of knowledge and areas in need of further development in this area.
|Original language||English (US)|
|Journal||Journal of acquired immune deficiency syndromes (1999)|
|State||Published - Aug 15 2016|
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)